Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Growth 2022-2028
Anti-vascular endothelial growth factor therapy, also known as anti-VEGF therapy or medication, is the use of medications that block vascular endothelial growth factor.
The global market for Anti-Vascular Endothelial Growth Factor Therapeutic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Anti-Vascular Endothelial Growth Factor Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Anti-Vascular Endothelial Growth Factor Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Anti-Vascular Endothelial Growth Factor Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Anti-Vascular Endothelial Growth Factor Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Anti-Vascular Endothelial Growth Factor Therapeutic players cover Regeneron Pharmaceuticals, Bayer, Novartis, Roche and Biogen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Anti-Vascular Endothelial Growth Factor Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Anti-Vascular Endothelial Growth Factor Therapeutic market, with both quantitative and qualitative data, to help readers understand how the Anti-Vascular Endothelial Growth Factor Therapeutic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Anti-Vascular Endothelial Growth Factor Therapeutic market and forecasts the market size by Type (Aflibercept (Eylea), Ranibizumab (Lucentis) and Brolucizumab (Beovu)), by Application (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion and Age-related Macular Degeneration), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Aflibercept (Eylea)
Ranibizumab (Lucentis)
Brolucizumab (Beovu)
Others
Segmentation by application
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Regeneron Pharmaceuticals
Bayer
Novartis
Roche
Biogen
Pfizer
Coherus BioSciences
Amgen
Bausch Health Companies
Viatris
Chapter Introduction
Chapter 1: Scope of Anti-Vascular Endothelial Growth Factor Therapeutic, Research Methodology, etc.
Chapter 2: Executive Summary, global Anti-Vascular Endothelial Growth Factor Therapeutic market size (sales and revenue) and CAGR, Anti-Vascular Endothelial Growth Factor Therapeutic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anti-Vascular Endothelial Growth Factor Therapeutic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anti-Vascular Endothelial Growth Factor Therapeutic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anti-Vascular Endothelial Growth Factor Therapeutic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Regeneron Pharmaceuticals, Bayer, Novartis, Roche, Biogen, Pfizer, Coherus BioSciences, Amgen and Bausch Health Companies, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Vascular Endothelial Growth Factor Therapeutic by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Vascular Endothelial Growth Factor Therapeutic by Country/Region, 2017, 2022 & 2028
2.2 Anti-Vascular Endothelial Growth Factor Therapeutic Segment by Type
2.2.1 Aflibercept (Eylea)
2.2.2 Ranibizumab (Lucentis)
2.2.3 Brolucizumab (Beovu)
2.2.4 Others
2.3 Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
2.3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Type (2017-2022)
2.4 Anti-Vascular Endothelial Growth Factor Therapeutic Segment by Application
2.4.1 Macular Edema
2.4.2 Diabetic Retinopathy
2.4.3 Retinal Vein Occlusion
2.4.4 Age-related Macular Degeneration
2.4.5 Others
2.5 Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
2.5.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Application (2017-2022)
3 Global Anti-Vascular Endothelial Growth Factor Therapeutic by Company
3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Breakdown Data by Company
3.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Company (2020-2022)
3.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Company (2020-2022)
3.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Company
3.4 Key Manufacturers Anti-Vascular Endothelial Growth Factor Therapeutic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Vascular Endothelial Growth Factor Therapeutic Product Location Distribution
3.4.2 Players Anti-Vascular Endothelial Growth Factor Therapeutic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Vascular Endothelial Growth Factor Therapeutic by Geographic Region
4.1 World Historic Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Revenue by Geographic Region
4.2 World Historic Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Revenue by Country/Region
4.3 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Growth
4.4 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Growth
4.5 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Growth
4.6 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Growth
5 Americas
5.1 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country
5.1.1 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022)
5.1.2 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022)
5.2 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
5.3 Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region
6.1.1 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2017-2022)
6.1.2 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2017-2022)
6.2 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
6.3 APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic by Country
7.1.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022)
7.1.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022)
7.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
7.3 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic by Country
8.1.1 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
8.3 Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Vascular Endothelial Growth Factor Therapeutic
10.3 Manufacturing Process Analysis of Anti-Vascular Endothelial Growth Factor Therapeutic
10.4 Industry Chain Structure of Anti-Vascular Endothelial Growth Factor Therapeutic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Vascular Endothelial Growth Factor Therapeutic Distributors
11.3 Anti-Vascular Endothelial Growth Factor Therapeutic Customer
12 World Forecast Review for Anti-Vascular Endothelial Growth Factor Therapeutic by Geographic Region
12.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Forecast by Region
12.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecast by Region (2023-2028)
12.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecast by Type
12.7 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecast by Application
13 Key Players Analysis
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.1.3 Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.2.3 Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.3.3 Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.4.3 Roche Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.5.3 Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.6.3 Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Coherus BioSciences
13.7.1 Coherus BioSciences Company Information
13.7.2 Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.7.3 Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Coherus BioSciences Main Business Overview
13.7.5 Coherus BioSciences Latest Developments
13.8 Amgen
13.8.1 Amgen Company Information
13.8.2 Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.8.3 Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Amgen Main Business Overview
13.8.5 Amgen Latest Developments
13.9 Bausch Health Companies
13.9.1 Bausch Health Companies Company Information
13.9.2 Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.9.3 Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bausch Health Companies Main Business Overview
13.9.5 Bausch Health Companies Latest Developments
13.10 Viatris
13.10.1 Viatris Company Information
13.10.2 Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
13.10.3 Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Viatris Main Business Overview
13.10.5 Viatris Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Vascular Endothelial Growth Factor Therapeutic Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aflibercept (Eylea)
Table 4. Major Players of Ranibizumab (Lucentis)
Table 5. Major Players of Brolucizumab (Beovu)
Table 6. Major Players of Others
Table 7. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2017-2022) & (K Units)
Table 8. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
Table 9. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2017-2022) & ($ million)
Table 10. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2017-2022)
Table 11. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2017-2022) & (K Units)
Table 13. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Table 14. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2017-2022)
Table 15. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2017-2022)
Table 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Company (2020-2022) & (K Units)
Table 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Company (2020-2022)
Table 19. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Company (2020-2022)
Table 21. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Anti-Vascular Endothelial Growth Factor Therapeutic Producing Area Distribution and Sales Area
Table 23. Players Anti-Vascular Endothelial Growth Factor Therapeutic Products Offered
Table 24. Anti-Vascular Endothelial Growth Factor Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share Geographic Region (2017-2022)
Table 29. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country/Region (2017-2022)
Table 33. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022) & (K Units)
Table 36. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2017-2022)
Table 37. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2017-2022)
Table 39. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2017-2022) & (K Units)
Table 40. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
Table 41. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2017-2022) & (K Units)
Table 42. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Table 43. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2017-2022) & (K Units)
Table 44. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2017-2022)
Table 45. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2017-2022)
Table 47. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2017-2022) & (K Units)
Table 48. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
Table 49. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2017-2022) & (K Units)
Table 50. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Table 51. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022) & (K Units)
Table 52. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2017-2022)
Table 53. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2017-2022)
Table 55. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2017-2022) & (K Units)
Table 56. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
Table 57. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2017-2022) & (K Units)
Table 58. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Anti-Vascular Endothelial Growth Factor Therapeutic
Table 68. Key Market Challenges & Risks of Anti-Vascular Endothelial Growth Factor Therapeutic
Table 69. Key Industry Trends of Anti-Vascular Endothelial Growth Factor Therapeutic
Table 70. Anti-Vascular Endothelial Growth Factor Therapeutic Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Anti-Vascular Endothelial Growth Factor Therapeutic Distributors List
Table 73. Anti-Vascular Endothelial Growth Factor Therapeutic Customer List
Table 74. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Forecast by Region
Table 76. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share Forecast by Application (2023-2028)
Table 94. Regeneron Pharmaceuticals Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 95. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 96. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Regeneron Pharmaceuticals Main Business
Table 98. Regeneron Pharmaceuticals Latest Developments
Table 99. Bayer Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 101. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Novartis Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 106. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Roche Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 110. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 111. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Roche Main Business
Table 113. Roche Latest Developments
Table 114. Biogen Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 115. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 116. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Biogen Main Business
Table 118. Biogen Latest Developments
Table 119. Pfizer Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 121. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Coherus BioSciences Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 125. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 126. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Coherus BioSciences Main Business
Table 128. Coherus BioSciences Latest Developments
Table 129. Amgen Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 130. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 131. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Amgen Main Business
Table 133. Amgen Latest Developments
Table 134. Bausch Health Companies Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 135. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 136. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Bausch Health Companies Main Business
Table 138. Bausch Health Companies Latest Developments
Table 139. Viatris Basic Information, Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturing Base, Sales Area and Its Competitors
Table 140. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Product Offered
Table 141. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Viatris Main Business
Table 143. Viatris Latest Developments
List of Figures
Figure 1. Picture of Anti-Vascular Endothelial Growth Factor Therapeutic
Figure 2. Anti-Vascular Endothelial Growth Factor Therapeutic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aflibercept (Eylea)
Figure 10. Product Picture of Ranibizumab (Lucentis)
Figure 11. Product Picture of Brolucizumab (Beovu)
Figure 12. Product Picture of Others
Figure 13. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type in 2021
Figure 14. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2017-2022)
Figure 15. Anti-Vascular Endothelial Growth Factor Therapeutic Consumed in Macular Edema
Figure 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market: Macular Edema (2017-2022) & (K Units)
Figure 17. Anti-Vascular Endothelial Growth Factor Therapeutic Consumed in Diabetic Retinopathy
Figure 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market: Diabetic Retinopathy (2017-2022) & (K Units)
Figure 19. Anti-Vascular Endothelial Growth Factor Therapeutic Consumed in Retinal Vein Occlusion
Figure 20. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market: Retinal Vein Occlusion (2017-2022) & (K Units)
Figure 21. Anti-Vascular Endothelial Growth Factor Therapeutic Consumed in Age-related Macular Degeneration
Figure 22. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market: Age-related Macular Degeneration (2017-2022) & (K Units)
Figure 23. Anti-Vascular Endothelial Growth Factor Therapeutic Consumed in Others
Figure 24. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market: Others (2017-2022) & (K Units)
Figure 25. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2017-2022)
Figure 26. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application in 2021
Figure 27. Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Company in 2021
Figure 29. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Geographic Region in 2021
Figure 31. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2017-2022)
Figure 32. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country/Region in 2021
Figure 33. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales 2017-2022 (K Units)
Figure 34. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue 2017-2022 ($ Millions)
Figure 35. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales 2017-2022 (K Units)
Figure 36. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue 2017-2022 ($ Millions)
Figure 37. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales 2017-2022 (K Units)
Figure 38. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue 2017-2022 ($ Millions)
Figure 41. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country in 2021
Figure 42. Americas Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country in 2021
Figure 43. United States Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region in 2021
Figure 48. APAC Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Regions in 2021
Figure 49. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country in 2021
Figure 56. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country in 2021
Figure 57. Germany Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country in 2021
Figure 64. Egypt Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Anti-Vascular Endothelial Growth Factor Therapeutic in 2021
Figure 70. Manufacturing Process Analysis of Anti-Vascular Endothelial Growth Factor Therapeutic
Figure 71. Industry Chain Structure of Anti-Vascular Endothelial Growth Factor Therapeutic
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets